As if on cue, a writer flies off the handle over the A-Rod/Galea thing

0 Comments

Reading the papers this morning I was surprised to see that neither Lupica nor any of the Post guys really brought the crazy in regards to this Alex Rodriguez/Dr. Galea thing. Oh, Lupica tried to muster some outrage, but his heart just wasn’t in it. I was almost prepared to give up and write a post about how unexpectedly level-headed everyone was being, but then I stumbled upon Ian O’Connor’s column in the Bergen Record:

But no, realistically, this isn’t about someone else. It’s about Alex
Rodriguez. It’s about a once-in-a-generation ballplayer who cheated the
game, cheated the fans and cheated himself, and who now is discovering
that even a World Series ring and ticker-tape parade can’t absolve him
of his not-so-venial steroid sins . . . Rodriguez also is waiting for a break in the storm clouds that never
will come. A-Rod’s waiting for the day when he’s completely liberated
from his admitted past as a chemically altered fraud. He shouldn’t hold his breath . . .

. . . It’s quite possible Rodriguez will tell the feds he never received
performance-enhancing drugs from Galea or anyone else, and this
flare-up will go away. At least until the next  flare-up. It’s
also possible Rodriguez will tell investigators a different tale, one
that could earn him a minimum 50-game suspension . . . It sounds unlikely, but when it’s A-Rod, worst-case scenarios are always in play.

And the prose gets even more purple after that if you can believe it.  All as a result of A-Rod being asked to answer a few questions about something he says doesn’t even involve him and which the Commissioner of Baseball and everyone else has said is a non-issue as far as baseball is concerned.

Of course O’Conner was probably pretty proud of that “cheated the
game, cheated the fans and cheated himself” line when he wrote it last year and it would have been a shame to have left it in unused macro purgatory for much longer.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.